Gilead Sciences (NASDAQ: GILD) revenue
Gilead Sciences reported revenue of $29,443m for fiscal 2025, 2.4% more than in fiscal 2024 ($28,754m). Since fiscal 2016 its revenue has fallen by 3.1%, an average decline of 0.4% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $29,443m | +2.4% | $10,022m | 34.0% |
| 2024 | $28,754m | +6.0% | $1,662m | 5.8% |
| 2023 | $27,116m | −0.6% | $7,605m | 28.0% |
| 2022 | $27,281m | −0.1% | $7,330m | 26.9% |
| 2021 | $27,305m | +10.6% | $9,918m | 36.3% |
| 2020 | $24,689m | +10.0% | $4,071m | 16.5% |
| 2019 | $22,449m | +1.5% | $4,287m | 19.1% |
| 2018 | $22,127m | −15.2% | $8,200m | 37.1% |
| 2017 | $26,107m | −14.1% | $14,124m | 54.1% |
| 2016 | $30,390m | — | $17,633m | 58.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Gilead Sciences
- How much revenue did Gilead Sciences make in fiscal 2025?
- Gilead Sciences reported revenue of $29,443m for fiscal 2025, compared with $28,754m in fiscal 2024.
- How much has the revenue of Gilead Sciences fallen?
- Between fiscal 2016 and fiscal 2025 it went from $30,390m to $29,443m: 3.1% less, an average decline of 0.4% a year.
- What was the best year for revenue at Gilead Sciences?
- Of its last 10 fiscal years, fiscal 2016, with $30,390m.
- Where do the figures for Gilead Sciences come from?
- From the annual report (Form 10-K) that Gilead Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Gilead Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Gilead Sciences: the Gilead Sciences page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Gilead Sciences by fiscal year, with the filing behind every figure: Gilead Sciences dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.